KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $9.9 billion.

  • Eli Lilly's Cash & Current Investments rose 18176.16% to $9.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 billion, marking a year-over-year increase of 18176.16%. This contributed to the annual value of $3.4 billion for FY2024, which is 1692.45% up from last year.
  • Latest data reveals that Eli Lilly reported Cash & Current Investments of $9.9 billion as of Q3 2025, which was up 18176.16% from $3.5 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Cash & Current Investments ranged from a high of $9.9 billion in Q3 2025 and a low of $2.2 billion during Q4 2022
  • Its 5-year average for Cash & Current Investments is $3.5 billion, with a median of $3.2 billion in 2025.
  • In the last 5 years, Eli Lilly's Cash & Current Investments tumbled by 4341.2% in 2022 and then surged by 18176.16% in 2025.
  • Over the past 5 years, Eli Lilly's Cash & Current Investments (Quarter) stood at $3.9 billion in 2021, then tumbled by 43.41% to $2.2 billion in 2022, then soared by 32.37% to $2.9 billion in 2023, then grew by 16.92% to $3.4 billion in 2024, then skyrocketed by 189.6% to $9.9 billion in 2025.
  • Its Cash & Current Investments stands at $9.9 billion for Q3 2025, versus $3.5 billion for Q2 2025 and $3.2 billion for Q1 2025.